Yubo International Biotech Limited Share Price Other OTC
Equities
YBGJ
US9883661004
Biotechnology & Medical Research
Sales 2022 | 0.1 8.31 | Sales 2023 | 0.6 48.2 | Capitalization | 35.95M 2.87B |
---|---|---|---|---|---|
Net income 2022 | -1M -79.71M | Net income 2023 | -1M -79.71M | EV / Sales 2022 | 116,560,264 x |
Net Debt 2022 | 772K 61.56M | Net Debt 2023 | 386K 30.73M | EV / Sales 2023 | 60,084,725 x |
P/E ratio 2022 |
-9.36
x | P/E ratio 2023 |
-30.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 6.63% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Wang
CEO | Chief Executive Officer | 57 | 31/12/18 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 31/12/18 |
Wang Yang
BRD | Director/Board Member | 45 | 31/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wang Yang
BRD | Director/Board Member | 45 | 31/12/18 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 31/12/18 |
Zhi Hui Bai
BRD | Director/Board Member | 39 | 31/12/19 |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |